Skip to content

Cardiovascular and Neurovascular Regulation in GWI

Autonomic Dysfunction, Brain Blood Flow and Cognitive Decline in Veterans With Gulf War Illness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04586049
Enrollment
70
Registered
2020-10-14
Start date
2023-05-16
Completion date
2026-06-30
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Blood Flow, Neurovascular Control

Keywords

MRI, Brain Blood Flow, Sympathetic Nerve Activity, Cardiorespiratory Fitness

Brief summary

Brain blood flow regulation and autonomic dysfunction will be measured in Veterans with and without Gulf War Illness who served in the Gulf War between 1990 and 1992.

Detailed description

Gulf War Illness (GWI) is a multi-symptom illness with unknown etiology. GWI is a leading cause of disability in Gulf War Veterans. Cognitive complaints are a common symptom of GWI, which suggests the brain is involved in the development of this condition. As Veterans age, these cognitive complaints may worsen and be compounded by the aging process. GWI may be a condition of accelerated brain aging. Therefore, there may be long-term consequences of GWI, and the presence of GWI may increase a person's risk for developing Alzheimer's Disease (AD) or other dementias. In comparison to other brain-related diseases such as stroke, relatively little is known about GWI and how this condition impacts the normal age-related changes in the brain. The research aims are: 1. To determine if Veterans with Gulf War Illness demonstrate abnormal brain blood flow regulation and autonomic dysfunction when compared with Veterans without Gulf War Illness. 2. To determine if brain blood flow and autonomic nervous system variables in Veterans are associated with other markers of brain aging that are relevant to cognitive decline.

Interventions

DEVICEMRI

Participants will undergo an MRI scan while participating in a breathing test to measure brain blood flow.

Participants will undergo a TCD scan while participating in a breathing test to measure brain blood flow.

Participants will undergo sympathetic nerve activity testing while participating in a breathing test.

Sponsors

United States Department of Defense
CollaboratorFED
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 68 Years
Healthy volunteers
Yes

Inclusion criteria

* Deployed to the Persian Gulf between 1990-1992 * Body mass \<300 lbs * Diagnosis of Gulf War Illness based on CMI/CDC and Kansas definitions or No diagnosis of Gulf War Illness

Exclusion criteria

* Current or lifetime evidence of: Type II diabetes, neurological disease, cancer treatment, rheumatoid arthritis, lupus, bipolar disorder, psychotic disorders, or mood disorders with psychotic features * Current illicit substance use or partial remission for less than 1 year * Taking multiple sedatives or anticonvulsant medications * Currently pregnant * Absolute contraindications to exercise testing * Contraindications to MRI * Other significant medical conditions at investigator's discretion

Design outcomes

Primary

MeasureTime frameDescription
Brain blood flow measured using Transcranial Doppler ultrasoundBaselineNeurovascular control will be investigated by measuring the change in brain blood flow using a transcranial Doppler ultrasound in response to a breathing test.
Brain blood flow measured using MRIBaselineNeurovascular control will be investigated by measuring the change in brain blood flow using an MRI in response to a breathing test.
Sympathetic nerve activityBaselineNeurovascular control will be investigated by measuring the change in sympathetic nerve activity will be measured using microneurography in response to a breathing test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026